Get started
Author

Huihuang Yan

Observed name: Yan Huihuang
Institution: Mayo Clinic
Observed institution: Mayo Clinic
OpenAlex ID: A5110156049
Comparative genomic analysis of sequences sampled from a small region on soybean (Glycine max) molecular linkage group G
2002 · Dawn Foster-Hartnett, Joann Mudge, et al. · Genome · 44
Soybean bacterial artificial chromosome contigs anchored with RFLPs: insights into genome duplication and gene clustering
2004 · Joann Mudge, Yan Huihuang, et al. · Genome · 25
ChIP-seq in Studying Epigenetic Mechanisms of Disease and Promoting Precision Medicine: Progresses and Future Directions
2016 · Huihuang Yan, Shulan Tian, et al. · Epigenomics · 24
Visualization of Oryza eichingeri chromosomes in intergenomic hybrid plants from O. sativa × O. eichingeri via fluorescent in situ hybridization
1999 · Huihuang Yan, Shaokai Min, et al. · Genome · 6
Abstract 5180: Enhanced and controlled chromatin extraction for chromatin-based epigenetic assays in FFPE tissues
2019 · Jian Zhong, Zhenqing Ye, et al. · Cancer Research · 1
Abstract 3015: IMiDs and BET inhibitors target distinct pathways of MYC dysregulation by super-enhancers in multiple myeloma
2019 · Daniel L. Riggs, Camille Herzog, et al. · Cancer Research · 1
Genomic profiling reveals molecular heterogeneity in patients with Richter transformation (RT) and chronic lymphocytic leukemia (CLL)
2025 · Shulan Tian, Hanyin Wang, et al. · Leukemia Research
Cyclin D1 beyond the cell cycle: A new role in t(11;14) multiple myeloma
2025 · Huihuang Yan, Aneta Mikulasova, et al. · Blood
PDF
The Role of NOXA in Venetoclax Treatment Response in Multiple Myeloma
2024 · Suganti Shivaram, Huihuang Yan, et al. · Blood
Targeting Aberrant DLK1 Re-Expression in ASXL1-Mutant Chronic Myelomonocytic Leukemia with BRD4 / p300-Directed Epigenetic Small Molecule Therapy
2024 · Terra L. Lasho, Jenna A. Fernandez, et al. · Blood
PDF
Data from Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas
2023 · Elizabeth Lenkiewicz, Smriti Malasi, et al.
Figure S1 from Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas
2023 · Elizabeth Lenkiewicz, Smriti Malasi, et al.
Table S1 from Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas
2023 · Elizabeth Lenkiewicz, Smriti Malasi, et al.
Figure S2 from Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas
2023 · Elizabeth Lenkiewicz, Smriti Malasi, et al.
Figure S8 from Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas
2023 · Elizabeth Lenkiewicz, Smriti Malasi, et al.
Figure S6 from Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas
2023 · Elizabeth Lenkiewicz, Smriti Malasi, et al.
Figure S4 from Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas
2023 · Elizabeth Lenkiewicz, Smriti Malasi, et al.
Figure S7 from Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas
2023 · Elizabeth Lenkiewicz, Smriti Malasi, et al.
Figure S3 from Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas
2023 · Elizabeth Lenkiewicz, Smriti Malasi, et al.
Table S2 from Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas
2023 · Elizabeth Lenkiewicz, Smriti Malasi, et al.
Figure S5 from Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas
2023 · Elizabeth Lenkiewicz, Smriti Malasi, et al.
Supplementary Materials from Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma
2023 · Rachael A. Vaubel, Shulan Tian, et al.
Table S6 from Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma
2023 · Rachael A. Vaubel, Shulan Tian, et al.
Table S1 from Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma
2023 · Rachael A. Vaubel, Shulan Tian, et al.
Table S4 from Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma
2023 · Rachael A. Vaubel, Shulan Tian, et al.
Works count: 52
Citation count: 101
H-index: 4
I10-index: 3
Year
Topic
Type